Tag: Mersana Therapeutics Inc

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Mersana Therapeutics Inc

$430000.00 in Sales Expected for Mersana Therapeutics, Inc. (NASDAQ:MRSN) This Quarter

Added to Collection on: 2020-12-05 07:30:00

Tags for this article:

Financial markets
Finance
Financial economics
Corporate finance
Stock
Stock market
Short
ANGI Homeservices
Price?earnings ratio
Mersana Therapeutics Inc
NASDAQ COMPOSITE INDEX

Click the tags to see associated articles and topics

View Article Details
Mersana Therapeutics Sees Unusually Large Options Volume (NASDAQ:MRSN)

Added to Collection on: 2020-12-14 20:37:30

Tags for this article:

Financial markets
Finance
Money
Equity securities
Corporate finance
Alternative investment management companies
Stock
Short
Price?earnings ratio
Share
Option
Hedge fund
Mersana Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Could Grow By 23.13% Or More

Added to Collection on: 2020-12-26 18:00:00

Tags for this article:

Financial markets
Finance
Money
Stock market
Exchange-traded funds
Share trading
Corporate finance
Stock
SPDR
Day trading
NASDAQ
Mersana Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT ...

Added to Collection on: 2021-04-10 12:56:15

Tags for this article:

Clinical medicine
Medicine
Cancer
Antineoplastic drugs
Oncology
Cancer treatments
Antibody-drug conjugate
Biotechnology
Immunology
Tumor microenvironment
Immunotherapy
Patient derived xenograft
Mersana Therapeutics Inc
Immunosynthen

Click the tags to see associated articles and topics

View Article Details
Mersana Therapeutics, Inc. Expected to Post Q2 2021 Earnings of ($0.51) Per Share (NASDAQ ...

Added to Collection on: 2021-05-13 12:45:00

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
Corporate finance
Financial ratios
Equity securities
Fundamental analysis
Dividend
Price?earnings ratio
Share
Stock
Mersana Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Timothy B. Lowinger Sells 4102 Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN) Stock

Added to Collection on: 2021-05-24 22:52:30

Tags for this article:

Finance
Financial markets
Money
Stock market
Corporate finance
Exchange-traded fund
Short
Stock
BlackRock
Price?earnings ratio
NASDAQ
Mersana Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Mersana Therapeutics, Inc.'s (NASDAQ:MRSN) CEO Will Probably Find It Hard To See A Huge ...

Added to Collection on: 2021-06-05 13:51:23

Tags for this article:

Financial markets
Corporate finance
Financial economics
Finance
Equity securities
Stock
Stock market
Executive compensation
Shareholders
Mersana Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Mersana Therapeutics Announces Target and Presents New Preclinical Data for XMT-2056 ...

Added to Collection on: 2021-10-07 20:03:45

Tags for this article:

Clinical medicine
Medicine
Medical specialties
Antineoplastic drugs
Immunology
Biotechnology
Cancer treatments
Antibody-drug conjugate
Pertuzumab
Trastuzumab
HER2/neu
Mersana Therapeutics Inc
Mersana Therapeutics

Click the tags to see associated articles and topics

View Article Details
What Type Of Shareholders Make Up Mersana Therapeutics, Inc.'s (NASDAQ:MRSN) Share ...

Added to Collection on: 2022-04-23 13:09:25

Tags for this article:

Finance
Money
Financial markets
Equity securities
Corporate finance
Stock market
Shareholders
Alternative investment management companies
Stock
Hedge fund
Equity
Private equity
Mersana Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Mersana Therapeutics announces collaboration with GSK for the co-development of cancer treatment

Added to Collection on: 2022-08-09 15:56:29

Tags for this article:

Medicine
Medical specialties
Clinical medicine
Genentech
Immunology
RTT
Antineoplastic drugs
Trastuzumab
Pertuzumab
HER2/neu
Breast cancer
Immune system
Mersana Therapeutics Inc
gsk plc

Click the tags to see associated articles and topics

View Article Details